Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kotaro Sakamoto

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Biochemistry and Biophysics Reports|October 14, 2022
Generation of KS-487 as a novel LRP1-binding cyclic peptide with higher affinity, higher stability and BBB permeabilityKotaro Sakamoto
Bioorganic & Medicinal Chemistry Letters|February 10, 2024
Lipid bilayer membrane permeability mechanism of the K-Ras(G12D)-inhibitory bicyclic peptide KS-58 elucidated by molecular dynamics simulationsKotaro Sakamoto, Takatsugu Hirokawa
Scientific Reports|December 11, 2020
Generation of KS-58 as the first K-Ras(G12D)-inhibitory peptide presenting anti-cancer activity in vivoKotaro Sakamoto, Teruaki Masutani, Takatsugu Hirokawa
Scientific Reports|January 10, 2023
Nanoformulation of the K-Ras(G12D)-inhibitory peptide KS-58 suppresses colorectal and pancreatic cancer-derived tumorsKotaro Sakamoto, Yun Qi, Eijiro Miyako
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|March 29, 2023
[Development of the vasoactive intestinal peptide receptor 2 (VIPR2) antagonist peptide for the treatment of schizophrenia]Yukio Ago, Satoshi Asano, Kotaro Sakamoto
Bioorganic & Medicinal Chemistry Letters|January 23, 2017
Discovery of peptidic miR-21 processing inhibitor by mirror image phage display: A novel method to generate RNA binding D-peptidesKotaro Sakamoto, Kentaro Otake, Tadashi Umemoto
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|April 30, 2025
[A novel drug target VIPR2 to regulate migration and proliferation in breast cancer]Satoshi Asano, Kotaro Sakamoto, Yukio Ago
Molecular Biology Reports|May 2, 2026
Epigenetic regulation of hyaluronan degradation and melanogenesis by Kawarayomogin I and II from Artemisia capillaris via miR-486-5p and miR-141-3pKazal Boron Biswas, Satoshi Nakagawa, Kotaro Sakamoto
Biochemical and Biophysical Research Communications|November 4, 2022
AlphaFold version 2.0 elucidates the binding mechanism between VIPR2 and KS-133, and reveals an S-S bond (Cys<sup>25</sup>-Cys<sup>192</sup>) formation of functional significance for VIPR2Kotaro Sakamoto, Satoshi Asano, Yukio Ago, et al.
The Journal of Biological Chemistry|June 22, 2006
Interaction of human lactoferrin with cell adhesion molecules through RGD motif elucidated by lactoferrin-binding epitopesKotaro Sakamoto, Yuji Ito, Toshiyuki Mori, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Biochemistry and Biophysics Reports|October 14, 2022
Generation of KS-487 as a novel LRP1-binding cyclic peptide with higher affinity, higher stability and BBB permeabilityKotaro Sakamoto
Bioorganic & Medicinal Chemistry Letters|February 10, 2024
Lipid bilayer membrane permeability mechanism of the K-Ras(G12D)-inhibitory bicyclic peptide KS-58 elucidated by molecular dynamics simulationsKotaro Sakamoto, Takatsugu Hirokawa
Scientific Reports|December 11, 2020
Generation of KS-58 as the first K-Ras(G12D)-inhibitory peptide presenting anti-cancer activity in vivoKotaro Sakamoto, Teruaki Masutani, Takatsugu Hirokawa
Scientific Reports|January 10, 2023
Nanoformulation of the K-Ras(G12D)-inhibitory peptide KS-58 suppresses colorectal and pancreatic cancer-derived tumorsKotaro Sakamoto, Yun Qi, Eijiro Miyako
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|March 29, 2023
[Development of the vasoactive intestinal peptide receptor 2 (VIPR2) antagonist peptide for the treatment of schizophrenia]Yukio Ago, Satoshi Asano, Kotaro Sakamoto
Bioorganic & Medicinal Chemistry Letters|January 23, 2017
Discovery of peptidic miR-21 processing inhibitor by mirror image phage display: A novel method to generate RNA binding D-peptidesKotaro Sakamoto, Kentaro Otake, Tadashi Umemoto
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|April 30, 2025
[A novel drug target VIPR2 to regulate migration and proliferation in breast cancer]Satoshi Asano, Kotaro Sakamoto, Yukio Ago
Molecular Biology Reports|May 2, 2026
Epigenetic regulation of hyaluronan degradation and melanogenesis by Kawarayomogin I and II from Artemisia capillaris via miR-486-5p and miR-141-3pKazal Boron Biswas, Satoshi Nakagawa, Kotaro Sakamoto
Biochemical and Biophysical Research Communications|November 4, 2022
AlphaFold version 2.0 elucidates the binding mechanism between VIPR2 and KS-133, and reveals an S-S bond (Cys<sup>25</sup>-Cys<sup>192</sup>) formation of functional significance for VIPR2Kotaro Sakamoto, Satoshi Asano, Yukio Ago, et al.
The Journal of Biological Chemistry|June 22, 2006
Interaction of human lactoferrin with cell adhesion molecules through RGD motif elucidated by lactoferrin-binding epitopesKotaro Sakamoto, Yuji Ito, Toshiyuki Mori, et al.
Pageof 7